Back to the Future: Dynamic Contrast-Enhanced Photon-Counting Detector CT for the Detection of Pituitary Adenoma in Cushing Disease

References

1. 1.↵
   1. Bonneville JF,
   2. Potorac I,
   3. Petrossians P, et al

   . Pituitary MRI in Cushing’s disease: an update. J Neuroendocrinol 2022;34:e13123 doi:10.1111/jne.13123 pmid:35352410

   CrossRefPubMed
2. 2.↵
   1. Friedman TC,
   2. Zuckerbraun E,
   3. Lee ML, et al

   . Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing’s syndrome and should be part of the initial workup. Horm Metab Res 2007;39:451–56 doi:10.1055/s-2007-980192 pmid:17578763

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Bashari WA,
   2. Gillett D,
   3. MacFarlane J, et al

   . Modern imaging in Cushing’s disease. Pituitary 2022;25:709–12 doi:10.1007/s11102-022-01236-w pmid:35666391

   CrossRefPubMed
4. 4.↵
   1. Nehra AK,
   2. Rajendran K,
   3. Baffour FI, et al

   . Seeing more with less: clinical benefits of photon-counting detector CT. Radiographics 2023;43:e220158 doi:10.1148/rg.220158 pmid:37022956

   CrossRefPubMed
5. 5.↵
   1. Rajendran K,
   2. Petersilka M,
   3. Henning A, et al

   . First clinical photon-counting detector CT system: technical evaluation. Radiology 2022;303:130–38 doi:10.1148/radiol.212579 pmid:34904876

   CrossRefPubMed
6. 6.↵
   1. Dane B,
   2. Qian K,
   3. Soni R, et al

   . Crohn’s disease inflammation severity assessment with iodine density from photon counting CT enterography: comparison with endoscopic histopathology. Abdom Radiology (NY) 2023;49:271–78 doi:10.1007/s00261-023-04060-3 pmid:37814149

   CrossRefPubMed
7. 7.↵
   1. Baffour FI,
   2. Glazebrook KN,
   3. Ferrero A, et al

   . Photon-counting detector CT for musculoskeletal imaging: a clinical perspective. AJR Am J Roentgenol 2023;220:551–60 doi:10.2214/AJR.22.28418 pmid:36259593

   CrossRefPubMed
8. 8.↵
   1. Madhavan AA,
   2. Yu L,
   3. Brinjikji W, et al

   . Utility of photon-counting detector CT myelography for the detection of CSF-venous fistulas. AJNR Am J Neuroradiol 2023;44:740–44 doi:10.3174/ajnr.A7887 pmid:37202116

   Abstract/FREE Full Text
9. 9.↵
   1. Benson JC,
   2. Rajendran K,
   3. Lane JI, et al

   . A new frontier in temporal bone imaging: photon-counting detector CT demonstrates superior visualization of critical anatomic structures at reduced radiation dose. AJNR Am J Neuroradiol 2022;43:579–84 doi:10.3174/ajnr.A7452 pmid:35332019

   Abstract/FREE Full Text
10. 10.↵
    1. Bonneville JF,
    2. Cattin F,
    3. Portha C, et al

    . Computed tomographic demonstration of the posterior pituitary. AJR Am J Roentgenol 1986;146:263–66 doi:10.2214/ajr.146.2.263 pmid:3484573

    CrossRefPubMed
11. 11.↵
    1. Stadnik T,
    2. Spruyt D,
    3. van Binst A, et al

    . Pituitary microadenomas: diagnosis with dynamic serial CT, conventional CT, and T1-weighted MR imaging before and after injection of gadolinium. Eur J Radiol 1994;18:191–98 doi:10.1016/0720-048x(94)90333-6 pmid:7957289

    CrossRefPubMed
12. 12.↵
    1. Kinoshita M,
    2. Tanaka H,
    3. Arita H, et al

    . Pituitary-targeted dynamic contrast-enhanced multisection CT for detecting MR imaging-occult functional pituitary microadenoma. AJNR Am J Neuroradiol 2015;36:904–08 doi:10.3174/ajnr.A4220 pmid:25593201

    Abstract/FREE Full Text
13. 13.↵
    1. Ntali G,
    2. Asimakopoulou A,
    3. Siamatras T, et al

    . Mortality in Cushing’s syndrome: systematic analysis of a large series with prolonged follow-up. Eur J Endocrinol 2013;169:715–23 doi:10.1530/EJE-13-0569 pmid:23996696

    Abstract/FREE Full Text
14. 14.↵
    1. Lonser RR,
    2. Wind JJ,
    3. Nieman LK, et al

    . Outcome of surgical treatment of 200 children with Cushing’s disease. J Clin Endocrinol Metab 2013;98:892–901 doi:10.1210/jc.2012-3604 pmid:23372173

    CrossRefPubMed